Bellevue Group Ag Axonics, Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $20.7 Million - $26.8 Million	-419,686 Reduced 18.63%	1,833,165 $114 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $1.43 Million - $1.84 Million	29,433 Added 1.32%	2,252,851 $126 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $15 Million - $18.8 Million	311,557 Added 16.3%	2,223,418 $112 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $284,040 - $363,636	5,400 Added 0.28%	1,911,861 $104 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $17.1 Million - $22 Million	-286,739 Reduced 13.07%	1,906,461 $119 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $6.99 Million - $9.43 Million	-120,652 Reduced 5.21%	2,193,200 $154 Million
Q2 2022 Aug 11, 2022	BUY	$39.5 - $64.42 $10.5 Million - $17 Million	264,647 Added 12.91%	2,313,852 $131 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $7.75 Million - $11.1 Million	177,191 Added 9.47%	2,049,205 $128 Million
Q4 2021 Feb 10, 2022	BUY	$50.01 - $73.35 $13.2 Million - $19.3 Million	263,220 Added 16.36%	1,872,014 $105 Million
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $7.2 Million - $9.57 Million	-121,677 Reduced 7.03%	1,608,794 $105 Million
Q2 2021 Aug 12, 2021	BUY	$51.39 - $66.9 $14.1 Million - $18.3 Million	274,197 Added 18.83%	1,730,471 $110 Million
Q1 2021 May 12, 2021	BUY	$49.14 - $59.89 $14.1 Million - $17.2 Million	287,296 Added 24.58%	1,456,274 $87.2 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $22.1 Million - $27 Million	524,034 Added 81.25%	1,168,978 $58.4 Million
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $4.54 Million - $6.56 Million	128,516 Added 24.89%	644,944 $32.9 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $7.72 Million - $13.4 Million	337,095 Added 187.97%	516,428 $18.1 Million
Q1 2020 May 14, 2020	BUY	$16.44 - $37.73 $2.95 Million - $6.77 Million	179,333 New	179,333 $4.56 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account